Lymphocytes recruit the immune system to fight most aggressive breast cancer, study confirms

Researchers at the UAB and the Hospital del Mar Research Institute have confirmed that patients with the presence of NK lymphocytes around tumors have a better response to treatment. This confirms the feasibility of using cytokines secreted by NK cells as markers of response to treatment with a simple blood test and supports the use of these lymphocytes to reinforce treatment in patients with metastatic HER2-positive breast cancer.

​Medical Xpress – latest medical and health news stories

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *